Skip to main content

Table 2 Intervention

From: Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications

Intervention (PAC)

Anticoagulation

Non-anticoagulation

p-value

Number

44

35

 

PAC treatment: (At initial presentation)

 Low dose LMWH, n (%)a

15 (34)

 High dose LMWH, n (%)b

7 (16)

 Warfarin with LMWH bridging, n (%)c

16 (36)

 Warfarin without bridging, n (%)

6 (13)

  

Anti-platelet treatmentd, n (%)

4 (9)

7 (20)

0.20

  1. Range: Minimum and maximum value; IQR: inter quartile range
  2. aDalteparin ≤5.000 IE/day or Enoxaparin 40 IE/day
  3. bDalteparin ≥7.500 IE/day or Enoxaparin 80 IE
  4. cWarfarin in combination with Dalteparin or Enoxaparin in any dose
  5. dAspirin 75 mg daily